Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XREF LIMITED Interim / Quarterly Report 2017

Jul 30, 2017

66097_rns_2017-07-30_9718051a-85ea-49e7-8f59-ad5b784e4ec3.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Appendix 4C

==> picture [158 x 34] intentionally omitted <==

Quarterly report for entities subject to Listing Rule 4.7B

Name of entity Xref Limited

Xref Limited
ARBN
122 404 666
Consolidated statement of cash flows
Quarterended ("current quarter")
30 June 2017
1
Cash flows from operating activities
1.1
Receipts from customers
1.2
Payments for
(a)
research and development
(b)
product manufacturing and operating costs
(c)
advertising and marketing
(d)
leased assets
(e)
staff costs
(f)
administration and corporate costs
1.3
Dividends received
1.4
Interest received
1.5
Interest and other costs of finance paid
1.6
Income taxes paid
1.7
Government grants and tax incentives
1.8
Other (provide details if material)
- Net GST received / (paid)
1.9
Net cash from / (used in) operating activities
Current
quarter
$A'000
838
(20)
(54)
(246)
(218)
(1,572)
(542)
-
21
-
-
-
(11)
Year to date
(12 months)
$A'000
3,200
(135)
(203)
(1,022)
(747)
(5,046)
(2,302)
-
53
-
2
482
13
(1,804) (5,705)
2
Cash flows from investing activities
2.1
Payments to acquire
(a)
property, plant and equipment
(b)
businesses (item 10)
(c)
investments
(d)
intellectual property
(e)
other non-current assets
2.2
Proceeds from disposal of:
(a)
property, plant and equipment
(b)
businesses (item 10)
(c)
investments
(d)
intellectual property
(e)
other non-current assets
2.3
Cash flows from loans to other entities
2.4
Dividends received (see note 3)
2.5
Other (provide details if material) -
2.6
Net cash from / (used in) investing activities
(34)
-
-
-
-
-
-
-
-
-
7
-
-
(122)
-
-
-
-
-
-
-
-
-
31
-
-
(27) (91)

Xref Limited

Page 1 of 3

Appendix 4C - 30 June 2017

3
3.1
3.2
3.3
Proceeds from exercise of share options
3.4
3.5
Proceeds from borrowings
3.6
Repayment of borrowings
3.7
3.8
Dividends paid
3.9
Other (provide details if material)
3.10
Net cash from / (used in) financing activities
Cash flows from financing activities
Transaction costs related to issues of shares, convertible
notes or options
Transaction costs related to loans and borrowings
Proceeds from issues of shares
Proceeds from issue of convertible notes
Current
quarter
$A'000
-
-
-
-
-
-
-
-
Year to date
(12 months)
$A'000
8,000
-
-
(540)
-
-
-
-
- 7,460
4
4.1
4.2
4.3
4.4
4.5
Effect of movement in exchange rates on cash held
4.6
Cash and cash equivalents at end of quarter
Net increase (decrease) in cash and cash equivalents
for the period held
Cash and cash equivalents at beginning of
quarter /year to date
Net cash from / (used in) operating activities
(item 1.9 above)
Net cash from / (used in) investing activities
(item 2.6 above)
Net cash from / (used in) financing activities
(item 3.10 above)
Current
quarter
$A'000
5,942
(1,804)
(27)
-
-


Year to date
(12 months)
$A'000
2,445
(5,705)
(91)
7,460
2
4,111 4,111
5
Reconciliation of cash and cash equivalents
5.1
Bank balances
5.2
Call deposits
5.3
Bank overdrafts
5.4
Other (provide details)
5.5
at the end of the quarter (as shown in the consolidated
statement of cash flows) to the related items in the
accounts
Cash and cash equivalents at end of quarter
Current
quarter
$A'000
4,040
71
-
-
Previous
quarter
$A'000
5,871
71
-
-
4,111 5,942
6
6.1
6.2
Aggregate amount of payments to these parties included
in item 1.2
Aggregate amount of cash flow from loans to these parties
included in item 2.3
Payments to directors of the entity and
associates of the directors
Current
quarter
$A'000
303
(5)
Current
quarter
$A'000
303
(5)
6.3
Include below any explanation necessary to understand
the transactions included in items 6.1 and 6.2

Xref Limited

Page 2 of 3

Appendix 4C - 30 June 2017

7
7.1
7.2
7.3
Aggregate amount of cash flow from loans to these parties
included in item 2.3
Aggregate amount of payments to these parties included
in item 1.2
Payments to related entities of the entity and
associates of the related entities
Include below any explanation necessary to understand
the transactionsincludedin 7.1and7.2
Current
quarter
$A'000
131
-

8 Financing facilities available


8.1
Loan facilities
8.2
Credit standby arrangements
8.3
Other (please specify)
Add notes as necessary for an understanding of
the position.
Total facility
amount at
quarter end
$A'000
-
-
-
Amount drawn at
quarter end
$A'000
-
-
-
8.4
Include below a description of each facility above, including the lender, interest rate and whether it
is secured or unsecured. If any additional facilities have been entered into or are proposed to be
entered into after quarter end, include details of those facilities as well.
  • 8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

  • 9 Estimated cash outflows for next quarter $A'000 9.1 Research and Development 30 9.2 Product manufacturing and operating costs 90 9.3 Advertising and marketing 385 9.4 Leased assets 220 9.5 Staff costs 1,950 9.6 Administration and corporate costs 290 9.7 Other (provide details if material) 9.8 Total estimated cash outflows 2,965 10 Acquisitions and disposals of business Acquisitions Disposals 10.1 n/a n/a

  • 10.1 Name of entity

  • 10.2 Place of incorporation or registration

  • 10.3 Consideration for acquisition or disposal

  • 10.4 Total net assets 10.5 Nature of business

Compliance statement

  • 1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

  • 2 This statement does give a true and fair view of the matters disclosed.

Sign here:

==> picture [85 x 40] intentionally omitted <==

Print name: James Solomons, CFO

Date: 31st July 2017

Xref Limited

Page 3 of 3

Appendix 4C - 30 June 2017